INFINITY PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Infinity Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Debt-to-equity for the quarter ending June 30, 2023 was -252 %, a 163% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 -252 -653 -163% Jun 30, 2023
Q1 2023 -413 -650 -274% Mar 31, 2023
Q4 2022 -1.18K -1.35K -806% Dec 31, 2022
Q3 2022 1.28K +1.04K +436% Sep 30, 2022
Q2 2022 401 -32.1 -7.41% Jun 30, 2022
Q1 2022 237 -6.64K -96.6% Mar 31, 2022
Q4 2021 168 +646 Dec 31, 2021
Q3 2021 240 +1.35K Sep 30, 2021
Q2 2021 434 -1.15K -72.6% Jun 30, 2021
Q1 2021 6.88K +6.54K +1950% Mar 31, 2021
Q4 2020 -478 -642 -392% Dec 31, 2020
Q3 2020 -1.11K -1.19K -1366% Sep 30, 2020
Q2 2020 1.58K +1.53K +3156% Jun 30, 2020
Q1 2020 335 +308 +1104% Mar 31, 2020
Q4 2019 164 +152 +1275% Dec 31, 2019
Q3 2019 87.4 +73.3 +519% Sep 30, 2019
Q2 2019 48.6 +31.6 +185% Jun 30, 2019
Q1 2019 27.9 -0.87 -3.03% Mar 31, 2019
Q4 2018 11.9 -24.2 -67% Dec 31, 2018
Q3 2018 14.1 -29 -67.3% Sep 30, 2018
Q2 2018 17.1 -31.7 -65% Jun 30, 2018
Q1 2018 28.7 -22 -43.3% Mar 31, 2018
Q4 2017 36.1 -57.2 -61.3% Dec 31, 2017
Q3 2017 43.2 -84.7 -66.3% Sep 30, 2017
Q2 2017 48.8 -106 -68.4% Jun 30, 2017
Q1 2017 50.7 -139 -73.3% Mar 31, 2017
Q4 2016 93.2 -63.4 -40.5% Dec 31, 2016
Q3 2016 128 +8.27 +6.92% Sep 30, 2016
Q2 2016 154 +62.3 +67.6% Jun 30, 2016
Q1 2016 190 +122 +179% Mar 31, 2016
Q4 2015 157 +109 +229% Dec 31, 2015
Q3 2015 120 +88.7 +287% Sep 30, 2015
Q2 2015 92.1 +76.8 +502% Jun 30, 2015
Q1 2015 67.8 +54.6 +412% Mar 31, 2015
Q4 2014 47.6 +36.2 +317% Dec 31, 2014
Q3 2014 30.9 +21 +212% Sep 30, 2014
Q2 2014 15.3 +6.09 +66% Jun 30, 2014
Q1 2014 13.3 -10.5 -44.3% Mar 31, 2014
Q4 2013 11.4 -43 -79% Dec 31, 2013
Q3 2013 9.91 -167 -94.4% Sep 30, 2013
Q2 2013 9.22 -847 -98.9% Jun 30, 2013
Q1 2013 23.8 -374 -94% Mar 31, 2013
Q4 2012 54.4 Dec 31, 2012
Q3 2012 177 Sep 30, 2012
Q2 2012 856 Jun 30, 2012
Q1 2012 397 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.